Methylphenidate Hydrochloride Tablet
Product Images NDC 71335-1219

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 71335-1219). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mg Sideeffects

This image shows a bulleted list of side effects including fast heartbeat, sweating, abnormal heartbeat (palpitations), decreased appetite, headache, dry mouth, trouble sleeping, nausea, nervousness, and stomach pain. The layout is simple black text on a white background without additional context.*

FDA Label Image

Lbl7133512192

Label for Methylphenidate 20 mg (CII) tablet by Bryant Ranch Prepack, packaged in Burbank, CA. The label indicates storage at room temperature (20-25°C / 68-77°F) and warns to keep all drugs out of reach of children. Includes a comparison to Ritalin 20 mg (CII) tablets by Ascent Pharmaceuticals Inc. The package contains 30 tablets. An NDC barcode and lot number are also shown.*

FDA Label Image

Methylphenidate Struct

Chemical structure of methylphenidate hydrochloride, showing its benzene ring, ester group, and piperidine ring linked to hydrochloride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.